CIK 0001401667 · Accelerated filer<br>Smaller reporting company
PUMA BIOTECHNOLOGY, INC.
Sign in to watch- Ticker
- PBYI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770683487
- Phone
- (424) 248-6500
- Business address
- 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
- Former names
- INNOVATIVE ACQUISITIONS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $612,494
- in 2 filings, $612K under 10b5-1 plans
Net −$612,494. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-13 | Stuglik Brian M Director | Sale 10b5-1 | −8,100 | $3.39 | $27K | 94,958 |
| 2025-06-13 | Senderowicz Adrian Director | Sale 10b5-1 | −27,000 | $3.40 | $92K | 27,000 |
| 2025-06-13 | MOYES JAY M Director | Sale 10b5-1 | −22,000 | $3.40 | $75K | 53,322 |
| 2025-06-13 | Dorval Allison Director | Sale 10b5-1 | −11,610 | $3.40 | $39K | 75,390 |
| 2025-06-13 | Cesano Alessandra Director | Sale 10b5-1 | −12,150 | $3.40 | $41K | 68,850 |
| 2025-06-11 | MILLER MICHAEL PATRICK Director | Grant or award | +27,000 | 74,000 | ||
| 2025-06-11 | Senderowicz Adrian Director | Grant or award | +27,000 | 54,000 | ||
| 2025-06-11 | MOYES JAY M Director | Grant or award | +27,000 | 75,322 | ||
| 2025-06-11 | Dorval Allison Director | Grant or award | +27,000 | 87,000 | ||
| 2025-06-11 | Stuglik Brian M Director | Grant or award | +27,000 | 103,058 | ||
| 2025-06-11 | WILSON TROY EDWARD Director | Grant or award | +27,000 | 54,350 | ||
| 2025-06-11 | Cesano Alessandra Director | Grant or award | +27,000 | 81,000 | ||
| 2025-02-07 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award | +61,456 | 213,751 | ||
| 2025-02-07 | NOUGUES MAXIMO F Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +85,067 | 85,067 | ||
| 2025-02-07 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award | +47,841 | 156,792 | ||
| 2025-02-07 | Ludwig Jeffrey Jerome Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +66,221 | 66,221 | ||
| 2025-02-07 | HUNT DOUGLAS M See Remarks | Grant or award | +48,117 | 172,711 | ||
| 2025-02-07 | HUNT DOUGLAS M See Remarks | Grant or award · Stock Option (Right to Buy) | +66,604 | 66,604 | ||
| 2025-02-07 | AUERBACH ALAN H President and CEO | Grant or award | +198,399 | 7,228,073 | ||
| 2025-02-07 | AUERBACH ALAN H President and CEO | Grant or award · Stock Option (Right to Buy) | +274,622 | 274,622 |
Page 3 of 7 · 137 trades